Cancer Treatment Reviews
Volume 24, Issue 1 , Pages 27-34 , February 1998

Chemotherapy in squamous cell carcinoma of the cervix uteri: Present role and perspectives

References 

  1. Coia L, Won M, Lanciano R, Marcial VA, Maitz K, Hanks G. The pattern of care outcome study for cancer of the uterine cervix. Cancer. 1990;66:2451–2456
  2. Perez CA, Breaux S, Madoc-Jones H. Radiation therapy alone in the treatment of carcinoma of uterine cervix. Cancer. 1983;51:1393–1402
  3. MHN Tattersall, Ramirez C, Coppleson M. A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer. Int J Gynecol Cancer. 1992;2:244–251
  4. In:  Petterson F editors. 21st annual report on the result of treatment in gynecological cancer. Int J Gynecol Cancer Obstet. 36:1991;p. 27–130 (Suppl.)
  5. Omura GA. Chemotherapy for cervix cancer. Semin Oncol. 1994;21:54–62
  6. Cannistra SA, Niloff JM. Cancer of the uterine cervix. New Engl J Med. 1996;334:1030–1038
  7. Bonomi P, Blessing JA, Stehman FB, DiSaia PJ, Walton L, Major FJ. Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol. 1985;3:1079–1085
  8. McGuire WP, Arsenau JC, Blessing JA. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynaecologic Oncology Group study. J Clin Oncol. 1989;7:1462–1468
  9. Vermoken JB, Zanetta G, De Oliveira CF, et al.  Cisplatin based chemotherapy (BEMP) versus single agent cisplatin (P) in disseminated squamous cell carcinoma of the uterine cervix: mature data EORTC protocol 55863. Ann Oncol. 1996;7:67
  10. Omura GA, Blessing JA, Vaccarello L, et al.  Randomized trial of cisplatinum versus cisplatinum plus mitolactolo, versus cisplatinum plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynaecologic Oncology Group study. J Clin Oncol. 1997;15:165–171
  11. McGuire WP, Blessing JA, Moore D, Lenz SS, Photopulos G. Paclitaxel has moderate activity in squamous cervix cancer: a Gynaecologic Oncology Group study. J Clin Oncol. 1996;14:792–795
  12. Kudelka AP, Winn R, Edwards CL, et al.  Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Clin Cancer Res. 1996;2:1285–1288
  13. Kudelka AP, Verschraegen CF, Levy T, et al.  Advanced squamous cell cancer of the cervix: a phase II study of docetaxel 100 mg/m2 over 1 h every 21 days: a preliminary report. In: Proc Annu Meet Am Soc Clin Oncol. 15:1996;p. A292
  14. Chevalier B, Lhomme C, Dieras V, et al.  Phase II study of CPT-111 in advanced cervical carcinoma. In: Proc Annu Meet Am Soc Clin Oncol. 14:1995;p. A267
  15. Verschraegen CF, Levy T, Kudelka AP, et al.  Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix. J Clin Oncol. 1997;15:625–631
  16. Noda K, Sasaki H, Yamamoto K, et al.  Phase II trial of tomoptecan for cervical cancer of the uterus. In: Proc Am Soc Clin Oncol. 15:1996;p. A296
  17. Goedhals L, Bezwoda WR. A phase II study of gemcitabine in advanced cervix carcinoma: final data. In: Proc Annu Meet Am Soc Clin Oncol. 15:1996;p. A754
  18. Lacava JA, Leone BA, Machiavelli M, et al.  Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma. J Clin Oncol. 1997;15:604–609
  19. Rose PG, Blessing JA, Gershenson DM. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous carcinoma of the cervix: a gynaecologic Oncology Group (GOG) study. In: Proc Am Soc Clin Oncol. 16:1997;p. A1291
  20. Hopkins MP, Morley GW. Radical hysterectomy versus radiation therapy for Stage IB squamous cell cancer of the cervix. Cancer. 1991;68:272–275
  21. Delgado G. Stage IB squamous cancer of the cervix: the choice of treatment. Obstet Gynecol Surv. 1987;33:174–178
  22. Fuller A, Elliot N, Kosloff C, et al.  Lymph node metastases from carcinoma of the cervix, Stages IB and IIA: Implications for prognosis and treatment. Gynecol Oncol. 1982;13:165–174
  23. Morrow C, Shingleton H, Austin J, et al.  Panel Report. In: Is pelvic radiation beneficial in the post-operative management of stage IB squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy?. Gynecol Oncol. 10:1980;p. 105–110
  24. Larson DM, Stringer CA, Copeland LJ, Gershenson DM, Malone JM, Rutledge FN. Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: Role of adjuvant radiotherapy. Obstet Gynecol. 1987;69:378–381
  25. Soisson A, Soper J, Clarke-Pearson D, Berchuck A, Montana G, Creasma W. Adjuvant radiotherapy following radical hysterectomy for patients with stage Ib and IIa cervical cancer. Gynecol Oncol. 1990;37:390–395
  26. Kinney W, Alvarez R, Reid G, et al.  Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early stage squamous carcinoma of the cervix with pelvic nodal metastasis: A matched-control study. Gynecol Oncol. 1989;34:258–262
  27. Vermorken JB. The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review. Int J Gynecol Cancer. 1993;3:129–142
  28. Buxton EJ, Saunders N, Blackledge GRP, et al.  The potential for adjuvant therapy in early-stage cervical cancer. Cancer Chemother Pharmacol. 1990;26:S17–S21
  29. Wertheim MS, Hakes TB, Daghestani AN, et al.  A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol. 1985;3:912–916
  30. Hakes T, Nori D, Lewis JL. Adjuvant cisplatin/bleomycin (C/B) for high risk stage Ib/IIa cervix carcinoma patients. In: A pilot study. Proc Am Soc Clin Oncol. 6:1987;p. A116
  31. Lai CH, Lin TS, Soong YK, Chen HF. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma. Gynecol Oncol. 1989;35:193–198
  32. Tattersall MHN, Ramirez C, Coppleson M. A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases. Gynecol Oncol. 1992;46:176–181
  33. Curtin JP, Hoskins WJ, Venkatraman ES, et al.  Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized Phase III trial. Gynecol Oncol. 1996;61:3–10
  34. Sardi J, Sananes C, Giaroli A, et al.  Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol. 1993;49:156–165
  35. Kim DS, Moon H, Kim KT, et al.  Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib and II with bulky tumor. Gynecol Oncol. 1989;33:225–230
  36. Giaroli A, Sananes C, Sardi JE, et al.  Lymph nodes metastases in carcinoma of the cervix uteri: response to neoadjuvant chemotherapy and its impact on survival. Gynecol Oncol. 1990;39:34–39
  37. Dottino PR, Plaxe SC, Beddoe A, et al.  Induction chemotherapy followed by radical surgery in cervical cancer. Gynecol Oncol. 1991;40:7–11
  38. Fontanelli R, Spatti G, Raspagliesi L, et al.  A pre-operative single course of high-dose cisplatin and bleomycin with glutathione protection in bulky stage Ib/II carcinoma of the cervix. Ann Oncol. 1992;3:117–121
  39. Benedetti Panici P, Scambia G, Baiocchi G, et al.  Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Cancer. 1991;67:372–379
  40. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol. 1975;46:507–510
  41. Fuller JR, Elliott N, Kosloff C, et al.  Lymph node metastases from carcinoma of the cervix, stage Ib and IIa: implications for prognosis and treatment. Gynecol Oncol. 1982;13:165–174
  42. Chung CK, Nahhas WA, Stryker JA, et al.  Analysis of factors contributing to treatment failures in stage Ib and IIa carcinoma of the cervix. Am J Obstet Gynecol. 1980;138:550–556
  43. Namkoong SE, Park JS, Kim JW, et al.  Comparative study of the patients with locally advanced stages I and II cervical cancer treated by radical surgery with and without preoperative adjuvant chemotherapy. Gynecol Oncol. 1996;59:136–142
  44. Braly PS, Lichter AS, Ash DK, et al.  In: Proc NIH Consensus Development Conference on Cervical Cancer. 1996;p. 1–29
  45. Steel GG, Peckman MJ. Exploitable mechanism in combined radiotherapy-chemotherapy: The concept of additivity. Int J Radiat Oncol Biol Phys. 1979;5:85–91
  46. Vokes EE, Weichselbaum RR. Concomitant chemotherapy: rational and clinical experience in patients with solid tumors. J Clin Oncol. 1990;8:911–934
  47. Rose PG. Locally advanced cervical carcinoma: the role of chemoradiation. Semin Oncol. 1994;21:47–53
  48. Thar T, Million R, Daly J. Radiation treatment of carcinoma of the cervix. Semin Oncol. 1982;9:299–311
  49. Tobias J, Buxton EJ, Blackledge G, et al.  Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer. Cancer Chemother Pharmacol. 1990;26:S 59–S 62
  50. Chauvergne J, Rohart J, Heron JF. Randomized phase III trial of neo-adjuvant chemotherapy (CT) + radiotherapy (RT) vs RT in stage IIB, III carcinoma of the cervix (CACX): a cooperative study of the French Oncology Centers. In: Proc Am Soc Clin Oncol. 10:1988;p. A136
  51. Souhami L, Gil RA, Allen SE, et al.  A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol. 1991;9:970–977
  52. Tatersall MNH, Lorvidhaya V, Vootiprux , et al.  A randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J Clin Oncol. 1995;13:444–451
  53. Kumar L, Kaushal R, Nandy M, et al.  Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study. Gynecol Oncol. 1994;54:307–315
  54. Withers HR, Taylor JMG, Maciejewskim B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1987;27:131–146
  55. Potish RA, Twiggs LB. On the lack of demonstrated clinical benefit of neoadjuvant cisplatin therapy for cervical cancer. Int J Radiation Oncol Biol Phys. 1993;27:975–979
  56. Benedetti Panici P, Greggi S, Scambia G, et al.  High-dose cisplatin and bleomycin neoadjuvant chemotherapy plus radical surgery in locally advanced cervical carcinoma: a preliminary report. Gynecol Oncol. 1991;41:212–216
  57. Chang HC, Lai CH, Chou PC. Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma. Cancer Chemother Pharmacol. 1992;30:281–285
  58. Kim DS, Moonm H, Hwangm YY, et al.  Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa and IIb with bulky tumor. Gynecol Oncol. 1988;29:321–332
  59. Piver MS, Barlow JJ, Vongtama V. Hydroxyurea and radiation therapy in advanced cervical cancer. Am J Obstet Gynecol. 1977;120:969–972
  60. Piver MS, Barlow JJ, Vongtama V. Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix. Am J Obstet Gynecol. 1977;129:379–383
  61. Piver MS, Vongtama V, Emrich LJ. Hydroxyurea plus pelvic radiation versus pelvic radiation in surgically staged stage IIIB cervical cancer. J Surg Oncol. 1987;35:129–134
  62. Hreschyshyn MM, Aron BS, Boronow RC et al. Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis. Int J Radiat Oncol Biol Phys 5: 317–322.
  63. Stehman FB, Bundy BN, Thomas G, et al.  Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol. 1993;11:1523–1528
  64. Park TK, Lee SK, Kim SN, et al.  Combined chemotherapy and radiation for bulky stages I–II cervical cancer: comparison of concurrent sequential regimens. Gynecol Oncol. 1993;50:196–201
  65. Souhami L, Seymour R, Roman TN, et al.  Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1993;27:871–878
  66. Malfetano J, Keys H, Kredentser D, Cunningham M, Kotlove D, Weiss L. Weekly cisplatin and radical radiation therapy for advanced, recurrent and poor prognosis cervical carcinoma. Cancer. 1993;72:11–16
  67. Vermorken JB. The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review. Int J Gynecol Cancer. 1993;3:129–142
  68. Choo YC, Choy TK, Wong LC, et al.  Potentiation of radiotherapy by cis-dichlorodiammine platinum (II) in advanced cervical carcinoma. Gynecol Oncol. 1986;23:94–100
  69. Wong LC, Choo YC, Choy D et al. Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer. Gynecol Oncol 35: 159–163. Thomas G, Dembo A, Beale T, et al.  Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: preliminary results of a phase I–II study. Int J Radiat Oncol Biol Phys. 1984;10:1785–1790
  70. Kuske RR, Perez CA, Grigsby PW, et al.  Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced and recurrent gynecologic malignancies. Am J Clin Oncol. 1989;12:467–473
  71. Roberts WS, Kawanagh JJ, Greenberg H et al. Concomitant radiation therapy and chemotherapy in the treatment of advanced squamous carcinoma of the lower female genital tract. Gynecol Oncol 34: 183–186.
  72. Rustin G, Newlands E. Cisplatinum, vincristine, methotrexate and bleomycin as initial or palliative chemotherapy for carcinoma of the cervix. Eur J Gynecol Oncol. 1987;8:337–341
  73. Friedlander M, Atkinson K, Coppleson J, et al.  The integration of chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol. 1984;19:1–7
  74. Kirsten F, Atkinson KH, Coppleson JVM. Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer. Br J Obstet Gynecol. 1987;94:583–588
  75. Sardi J, Giaroli A, Sananes C, et al.  Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma cervix uteri: an unexpected therapeutic management. Int J Gynecol Cancer. 1996;6:85–93

PII: S0305-7372(98)90069-X

Cancer Treatment Reviews
Volume 24, Issue 1 , Pages 27-34 , February 1998

Article Tools